Insights

Strategic Global Presence Transcenta has established a comprehensive global footprint with research and development centers in China and the US, along with clinical and manufacturing facilities. This extensive infrastructure suggests opportunities to partner on joint research, manufacturing services, or joint clinical trials across multiple regions.

Focused Therapeutic Portfolio The company's development of nine therapeutic antibody molecules targeting oncology and non-oncology indications positions it well for collaborations with biotech firms, healthcare providers, and pharmaceutical companies seeking innovative therapies for cancer, kidney, and bone disorders.

Upcoming Industry Engagements Transcenta's scheduled participation in the 2023 ASCO conference indicates active industry outreach, providing a platform to connect with potential collaborators, investors, and customers interested in antibody-based therapeutics and clinical stage innovations.

Growing Revenue Base With revenues estimated between $50 million and $100 million, Transcenta demonstrates a solid financial footing that can support strategic collaborations, licensing deals, or co-development projects with companies looking to expand their oncology and biotech pipelines.

Innovation in Biotech R&D The company's integrated approach to antibody discovery, research, development, and manufacturing suggests potential for partnering on custom R&D solutions, technology licensing, or contract manufacturing, appealing to firms seeking expertise in biotherapeutic development.

Similar companies to Transcenta

Transcenta Tech Stack

Transcenta uses 8 technology products and services including MATLAB, GSAP, Swiper, and more. Explore Transcenta's tech stack below.

MATLAB
Advanced Analytics And Data Science
GSAP
Javascript Frameworks
Swiper
Javascript Libraries
jQuery
Javascript Libraries
PHP
Programming Languages
Apache HTTP Server
Web Servers
Apache
Web Servers
jQuery custom content scroller
Web Tools And Plugins

Media & News

Transcenta Holding Limited (6628.HK) to Hold 2023 ASCO Business Update call Conference.
SUZHOU, China, June 2, 2023 /PRNewswire/ — The management team of Transcenta Holding Limited (06628.HK) will attend the 2023 ASCO Business Update Call conference on June 7, 2023. Transcenta is a clinical stage biopharmaceutical company with fully integrated capabilities in the discovery, research, development, and manufacture of antibodies-based therapeutics. Meeting Details: Meeting Date: Wednesday, June 7, […]...
Jun 02, 2023 | www.headlinesoftoday.com

Transcenta's Email Address Formats

Transcenta uses at least 1 format(s):

Transcenta Email Formats	Example	Percentage
First.Last@transcenta.com	John.Doe@transcenta.com	50%
First.Last@transcenta.com	John.Doe@transcenta.com	50%

Frequently Asked Questions

Where is Transcenta's headquarters located?

Transcenta's main headquarters is located at Princeton, Florida United States. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Transcenta's stock symbol?

Transcenta is a publicly traded company; the company's stock symbol is 6628.HK.

What is Transcenta's official website and social media links?

Transcenta's official website is transcenta.com and has social profiles on LinkedIn Crunchbase.

What is Transcenta's SIC code NAICS code?

Transcenta's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Transcenta have currently?

As of February 2026, Transcenta has approximately 92 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Vp And Head Of Clinical Pharmacology: Z. J. Y.Head Of Translational Science Operation: A. L.Head Of Information Technology: R. L.. Explore Transcenta's employee directory with LeadIQ.

What industry does Transcenta belong to?

Transcenta operates in the Biotechnology Research industry.

What technology does Transcenta use?

Transcenta's tech stack includes MATLABGSAPSwiperjQueryPHPApache HTTP ServerApachejQuery custom content scroller.

What is Transcenta's email format?

Transcenta's email format typically follows the pattern of First.Last@transcenta.com. Find more Transcenta email formats with LeadIQ.

Transcenta

Q: What is Transcenta's official website and social media links?

Transcenta's official website is transcenta.com. Transcenta has social profiles on LinkedIn.

Q: How many employees does Transcenta have currently?

Transcenta has approximately 92 employees.

Q: What technology does Transcenta use?

Transcenta's tech stack includes MATLAB, Swiper, PHP, jQuery, GSAP.

Biotechnology ResearchFlorida, United States51-200 Employees

Transcenta is a clinical stage biopharmaceutical company that fully integrates antibody-based biotherapeutics discovery, research, development and manufacturing. On September 29, 2021, Transcenta was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 06628.

Transcenta has established global footprint, with Headquarters and Discovery, Clinical and Translational Research Center in Suzhou, Process and Product Development Center and Manufacturing Facility in Hangzhou, and Clinical Development Centers in Beijing, Shanghai and Guangzhou in China and in Princeton, US, and External Partnering Center in Boston and Los Angeles, US. Transcenta is developing nine therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. 

For more information, please visit www.transcenta.com.

Company Overview

Headquarters: Princeton, Florida United States
Website: transcenta.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: 6628.HK
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 51-200